Baker Bros. Advisors LP Portfolio Holdings
Baker Bros. Advisors LP
- $9.34 Billion
- Q3 2024
Baker Bros. Advisors LP has filed its 13F form on November 14, 2024 for Q3 2024 where it was disclosed a total value porftolio of $9.34 Billion distributed in 93 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Bei Gene, Ltd. with a value of $2.37B, Incyte Corp with a value of $2.03B, Acadia Pharmaceuticals Inc with a value of $660M, Summit Therapeutics Inc. with a value of $535M, and Madrigal Pharmaceuticals, Inc. with a value of $419M.
Examining the 13F form we can see an increase of $1.81B in the current position value, from $7.52B to 9.34B.
Baker Bros. Advisors LP is based out at New York, NY
Below you can find more details about Baker Bros. Advisors LP portfolio as well as his latest detailed transactions.